TY - JOUR
T1 - Irreversible neurologic complications of metrizamide myelography
AU - Meador, Kimford
AU - Hamilton, William J.
AU - El Gammal, Taher A.M.
AU - Demetropoulos, K. C.
AU - Nichols, Fenwick T.
PY - 1984/6
Y1 - 1984/6
N2 - Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.
AB - Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.
UR - http://www.scopus.com/inward/record.url?scp=0021247463&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021247463&partnerID=8YFLogxK
U2 - 10.1212/wnl.34.6.817
DO - 10.1212/wnl.34.6.817
M3 - Article
C2 - 6539448
AN - SCOPUS:0021247463
SN - 0028-3878
VL - 34
SP - 817
EP - 821
JO - Neurology
JF - Neurology
IS - 6
ER -